LinkedIn Icon
April 22-25, 2019 | Boston, MA



Organovo: Spotlight Partner

Organovo develops dynamic, multi-cellular, and fully-human tissues that closely model native architecture and biology.  With the NovoGen Brioprinter® Platform, the Company designs tissues for use in applications spanning pre-clinical safety testing, disease modeling, and regenerative medicine. Tissues are commercially available through its NovoView™ Service Offering and through strategic partnerships. Organovo’s bioprinted tissues enable mechanistic insights into phenotypes that progress over time and that require multiple cell types in a specific spatial organization, reflecting the true complexity of human biology.